VCYT
Veracyte Inc
45.40$
-6.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.7% | 15.8% | -9.3% | 25.8% | 25.9% | 20.7% | 4.7% | 25.8% | 33.9% | 37.4% | 25.3% | 30.5% | 31.7% | |
| 8.1% | 6.5% | 5.8% | 5.0% | 5.1% | 5.3% | 4.7% | 4.2% | 4.0% | 3.8% | 3.9% | 3.2% | 3.7% | |
| 8.1% | 7.6% | 8.3% | 8.6% | 7.5% | 8.1% | 9.6% | 8.4% | 8.2% | 7.8% | 9.2% | 9.4% | 8.6% | |
| -1.7% | 1.5% | -23.6% | 5.1% | -0.1% | -3.5% | -12.7% | 0.3% | 4.8% | 3.9% | -8.4% | 1.8% | 0.5% | |
| 3.1% | 2.5% | 2.2% | 2.4% | 1.9% | 3.5% | 1.6% | 1.0% | 2.1% | 3.1% | 2.1% | 1.9% | 2.3% | |
| -3.1% | -2.5% | 3.0% | -2.4% | -1.9% | -45.6% | -45.3% | -0.2% | 36.6% | -3.9% | -92.0% | -9.0% | -17.6% | |
| -2.7% | -1.1% | -4.0% | -1.1% | -1.9% | -2.8% | -8.3% | -1.8% | – | – | – | -2.9% | – | |
| 0.1% | 0.7% | -0.9% | 0.0% | 8.9% | -3.8% | -5.7% | -0.4% | 2.3% | -0.1% | -4.8% | 2.8% | 0.1% | |
| 12.5% | 14.3% | -7.3% | 23.4% | 32.9% | -29.1% | -46.2% | 25.7% | 72.9% | 33.4% | -71.5% | 24.2% | 14.2% | |
| 12.6% | 13.3% | -11.5% | 23.4% | 23.9% | 17.2% | 3.1% | 24.8% | 31.8% | 34.3% | 23.2% | 28.6% | 29.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.